The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Newborn and carrier screening for spinal muscular atrophy
Abstract
Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder caused by mutations in the survival motor neuron (SMN1) gene, affecting approximately 1 in 10,000 live births. The homozygous absence of SMN1 exon 7 has been observed in the majority of patients and is being utilized as a reliable and sensitive SMA diagnostic test. Treatment and prevention of SMA are complementary responses to the challenges presented by SMA. Even though a specific therapy for SMA is not currently available, a newborn screening test may allow the child to be enrolled in a clinical trial before irreversible neuronal loss occurs and enable patients to obtain more proactive treatments. Until an effective treatment is found to cure or arrest the progression of the disease, prevention of new cases through accurate diagnosis and carrier and prenatal diagnosis is of the utmost importance. The goal of population‐based SMA carrier screening is to identify couples at risk for having a child with SMA, thus allowing carriers to make informed reproductive choices. During this study we performed two pilot projects addressing the clinical applicability of testing in the newborn period and carrier screening in the general population. We have demonstrated that an effective technology does exist for newborn screening of SMA. We also provide an estimate of the carrier frequency among individuals who accepted carrier screening, and report on patient's knowledge and attitudes toward SMA testing. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Wirth, B. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200003)15:3<228::aid-humu3>3.0.co;2-9 · Cited by 667
International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany)
Munsat, T. L., & Davies, K. E. (1992) · Neuromuscular Disorders · doi:10.1016/s0960-8966(06)80015-5 · Cited by 666
Zerres, K. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540290108025 · Cited by 563
McAndrew, P. E., Parsons, D. W., Simard, L. R., Rochette, C., Ray, P. N., Mendell, J. R., Prior, T. W., & Burghes, A. H. M. (1997) · The American Journal of Human Genetics · doi:10.1086/515465 · Cited by 543
Self-citationNatural history of denervation in SMA: Relation to age, SMN2 copy number, and function
Swoboda, K. J., Prior, T. W., Scott, C. B., McNaught, T. P., Wride, M. C., Reyna, S. P., & Bromberg, M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20473 · Cited by 478
Self-citationIncidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.
Pearn, J. (1978) · Journal of Medical Genetics · doi:10.1136/jmg.15.6.409 · Cited by 472
Wirth, B., Herz, M., Wetter, A., Moskau, S., Hahnen, E., Rudnik-Schöneborn, S., Wienker, T., & Zerres, K. (1999) · The American Journal of Human Genetics · doi:10.1086/302369 · Cited by 368
Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2
Mailman, M. D., Heinz, J. W., Papp, A. C., Snyder, P. J., Sedra, M. S., Wirth, B., Burghes, A. H. M., & Prior, T. W. (2002) · Genetics in Medicine · doi:10.1097/00125817-200201000-00004 · Cited by 364
Self-citationCampbell, L., Potter, A., Ignatius, J., Dubowitz, V., & Davies, K. (1997) · The American Journal of Human Genetics · doi:10.1086/513886 · Cited by 325
Carrier screening for spinal muscular atrophy
Prior, T. W. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e318188d069 · Cited by 270
Self-citationInternational SMA consortium meeting
Munsat, T. L. (1992) · Medical Entomology and Zoology · Cited by 243
Genetic testing and risk assessment for spinal muscular atrophy (SMA)
Ogino, S., & Wilson, R. (2002) · Human Genetics · doi:10.1007/s00439-002-0828-x · Cited by 205
Genetic risk assessment in carrier testing for spinal muscular atrophy
Ogino, S., Leonard, D. G. B., Rennert, H., Ewens, W. J., & Wilson, R. B. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10425 · Cited by 189
Wirth, B., Schmidt, T., Hahnen, E., Rudnik-Schöneborn, S., Krawczak, M., Müller-Myhsok, B., Schönling, J., & Zerres, K. (1997) · The American Journal of Human Genetics · doi:10.1086/301608 · Cited by 182
Parsons, D. W., McAndrew, P. E., Iannaccone, S. T., Mendell, J. R., Burghes, A. H. M., & Prior, T. W. (1998) · The American Journal of Human Genetics · doi:10.1086/302160 · Cited by 178
Self-citationPhase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy
Swoboda, K. J., Scott, C. B., Reyna, S. P., Prior, T. W., LaSalle, B., Sorenson, S. L., Wood, J., Acsadi, G., Crawford, T. O., Kissel, J. T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005268 · Cited by 176
Self-citationAlías, L., Bernal, S., Fuentes-Prior, P., Barceló, M. J., Also, E., Martínez-Hernández, R., Rodríguez-Alvarez, F. J., Martín, Y., Aller, E., Grau, E., et al. (2009) · Human Genetics · doi:10.1007/s00439-008-0598-1 · Cited by 173
Differences in SMN1 allele frequencies among ethnic groups within North America
Hendrickson, B. C., Donohoe, C., Akmaev, V. R., Sugarman, E. A., Labrousse, P., Boguslavskiy, L., Flynn, K., Rohlfs, E. M., Walker, A., Allitto, B., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066969 · Cited by 172
Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2
Prior, T. W., Swoboda, K. J., Scott, H. D., & Hejmanowski, A. Q. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30251 · Cited by 164
Self-citationPhenylbutyrate increases SMN gene expression in spinal muscular atrophy patients
Brahe, C., Vitali, T., Tiziano, F. D., Angelozzi, C., Pinto, A. M., Borgo, F., Moscato, U., Bertini, E., Mercuri, E. M., & Neri, G. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201320 · Cited by 156
In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate
Brichta, L., Hölker, I., Haug, K., Klockgether, T., & Wirth, B. (2006) · Annals of Neurology · doi:10.1002/ana.20836 · Cited by 138
Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy
Weihl, C. C., Connolly, A. M., & Pestronk, A. (2006) · Neurology · doi:10.1212/01.wnl.0000231139.26253.d0 · Cited by 121
Determination of SMN1 and SMN2 copy number using TaqMan™ technology
Anhuf, D., Eggermann, T., Rudnik‐Schöneborn, S., & Zerres, K. (2003) · Human Mutation · doi:10.1002/humu.10221 · Cited by 115
Cusin, V., Clermont, O., Gérard, B., Chantereau, D., & Élion, J. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.4.e39 · Cited by 86
Population screening and cascade testing for carriers of SMA
Smith, M. J., Calabro, V., Chong, B., Gardiner, N., Cowie, S., & du Sart, D. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201821 · Cited by 77
Neonatal screening by DNA microarray: spots and chips
Green, N., & Pass, K. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1526 · Cited by 69
G�rard, B., Ginet, N., Matthijs, G., Evrard, P., Baumann, C., Silva, F. D., Gérard‐Blanluet, M., Mayer, M., Grandchamp, B., & Élion, J. (2000) · Human Mutation · doi:10.1002/1098-1004(200009)16:3<253::aid-humu8>3.0.co;2-8 · Cited by 64
Huang, C., Chang, Y.-Y., Chen, C., Kuo, Y.-S., Hwu, W., Gerdes, T., & Ko, T. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31803d35bc · Cited by 61
Su, Y., Hung, C., Li, H., et al. (2005) · Human Mutation · doi:10.1002/humu.20160 · Cited by 60
Valproic acid treatment in six patients with spinal muscular atrophy
Tsai, L., Yang, C., Hwu, W., & Li, H. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01992.x · Cited by 53
Mailman, M. D., Hemingway, T., Darsey, R., et al. (2001) · Human Genetics · doi:10.1007/s004390000446 · Cited by 46
Carrier incidence for spinal muscular atrophy in southern Chinese
Chan, V., Yip, B., Yam, I., Au, P., Lin, C. K., Wong, V. C. N., & Chan, T. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0487-z · Cited by 36
Assessment of Liquid Microbead Arrays for the Screening of Newborns for Spinal Muscular Atrophy
Pyatt, R. E., Mihal, D. C., & Prior, T. W. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.092312 · Cited by 30
Self-citation
Cited by
Verhaart, I. E. C., Robertson, A., Wilson, I. J., Aartsma-Rus, A., Cameron, S., Jones, C. C., Cook, S. F., & Lochmüller, H. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0671-8 · Cited by 739
Sugarman, E. A., Nagan, N., Zhu, H., Akmaev, V. R., Zhou, Z., Rohlfs, E. M., Flynn, K., Hendrickson, B. C., Scholl, T., Sirko-Osadsa, D. A., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.134 · Cited by 661
Kolb, S. J., & Kissel, J. T. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.004 · Cited by 603
D'Amico, A., Mercuri, E., Tiziano, F. D., & Bertini, E. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-71 · Cited by 577
Splice-switching antisense oligonucleotides as therapeutic drugs
Havens, M. A., & Hastings, M. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw533 · Cited by 538
Metadata
- Authors
- Prior, T. W., Snyder, P. J., Rink, B. D., Pearl, D. K., Pyatt, R. E., Mihal, D. C., Conlan, T., Schmalz, B., Montgomery, L., Ziegler, K., Noonan, C., Hashimoto, S., & Garner, S.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2010-05-07
- Volume
- 152A
- Issue
- 7
- Pages
- 1608-1616
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W1991509584
- Cited by
- 268
- References
- 35
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.